TAP MENUE ICON TO VIEW NEXT PAGES
ON MOBILE DEVICES
UNITED STATES CONGRESS
SESSION OF 2026
IN THE HOUSE OF REPRESENTATIVES / SENATE
AUTHORED BY: John Dady
HEALTHCARE MARKETPLACE LIBERATION AND PLAN B REDUCTION ACT
AN ACT
To establish portability of Employer-Sponsored Insurance, eliminate anti-competitive mandates, eliminate Medicare Part B premiums, secure Social Security solvency, and for other related purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, as follows:
SECTION 1. CONGRESSIONAL FINDINGS AND CONSTITUTIONAL AUTHORITY
Congress finds the following:
* Employer-Sponsored Insurance Volume: Employer-Sponsored Insurance (ESI) represents earned worker compensation totaling over $1.5 trillion annually across approximately 157 million Americans, with employers contributing an average of 83 percent toward single coverage (approximately $8,130 annually) and 73 percent toward family coverage (approximately $20,830 annually) according to Kaiser Family Foundation benchmarks.
* The 1954 Tax Loophole: Sections 105 and 106 of the Internal Revenue Code of 1986 (26 U.S.C. §§ 105, 106) trap employer contributions inside corporate-controlled plans, sever consumer price sensitivity, restrict labor mobility, and exempt the employer-paid portion of ESI from Federal Insurance Contributions Act (FICA) payroll taxes (26 U.S.C. § 3101 et seq.).
* Constitutional Anchor — Commerce Clause (Article I, Section 8, Clause 3): Interstate healthcare monopolies, state-line insurance barriers, and Certificate of Need (CON) laws substantially affect and impede interstate commerce, justifying direct federal preemption.
* Constitutional Anchor — Taxing and Spending Clause (Article I, Section 8, Clause 1): Congress possesses plenary authority to restructure employer-sponsored tax exclusions, levy non-compliant corporate excise taxes, and condition federal Medicaid matching funds upon state adherence to market liberation standards.
* Artificial Supply Restrictions: Artificial supply restrictions inflate baseline medical and prescription drug prices by an estimated 40 percent through specific institutional barriers:
* State Certificate of Need (CON) laws that block healthcare facility entry and expansion;
* Restrictive provider scope-of-practice rules that limit clinical autonomy;
* State-line insurance monopolies that restrict interstate consumer choice; and
* Vertical consolidation among health insurers, Pharmacy Benefit Managers (PBMs), and hospital systems.
* Billing Opacity: Opaque hospital and pharmaceutical billing practices further distort medical markets, obscure true costs, and prevent transparent consumer price comparison.
SECTION 2. QUALIFIED HEALTH COVERAGE (QHC) STANDARDS AND PATIENT BILL OF RIGHTS
To be certified as a Qualified Health Coverage (QHC) plan eligible for purchase via personal HSAs or on the open market, a health insurance plan shall meet the following mandatory standards:
* (a) Guaranteed Issue and Renewability: No carrier or healthcare association may deny enrollment, re-enrollment, or renewal based on medical history, pre-existing conditions, health status, claim history, or gender.
* (b) Deductible as Total Annual Liability: The annual deductible shall serve as the absolute Total Annual Out-of-Pocket Maximum for all covered medical, surgical, diagnostic, inpatient, outpatient, and pharmaceutical care. Once satisfied, the patient owes $0.00 in further copays, coinsurance, or facility fees for the remainder of the calendar year.
* (c) Out-of-Pocket Caps and Unlimited Benefits: The Total Annual Out-of-Pocket Maximum (deductible) shall not exceed $5,000 for an individual or $7,500 for a family per calendar year. All certified QHC plans shall provide unlimited annual and lifetime aggregate benefit payouts; dollar caps, benefit limits, and exhaustion clauses are strictly prohibited.
* (d) 80 Percent Direct Medical Care Payout Mandate: At least 80 percent of all collected premium revenues must be expended directly on actual medical, surgical, diagnostic, inpatient, outpatient, and pharmaceutical care services. Executive compensation, bonuses, administrative overhead, legal fees, and marketing expenses are strictly excluded from this 80 percent calculation.
* (e) Rating Limits: Premiums for certified QHC plans are restricted to maximum variance ratios of 2-to-1 for age, 1.5-to-1 for tobacco use, and 1.5-to-1 for geographic location, with no medical underwriting.
* (f) Network Adequacy and Balance Billing Ban: If a QHC plan fails to maintain an in-network provider or facility within 35 miles of an insured individual's primary residence for necessary care, any out-of-network care obtained shall apply toward the annual deductible at in-network rates, and balance billing by providers or insurers is strictly prohibited.
SECTION 3. PHASE 1 — MARKET LIBERATION, PRICE TRANSPARENCY, AND PROVIDER EMPOWERMENT
* (a) True Cash Price Mandate (Month 6 Milestone): Not later than 6 months after enactment, 100 percent of hospitals, clinics, surgery centers, diagnostic facilities, retail pharmacies, mail-order distributors, and outpatient dispensaries shall publicly post and provide True Cash Prices for all procedures, services, and prescription medications, starting with the 300 Most Common Procedures and 300 Most Commonly Prescribed Medications. Pharmacies are prohibited from charging any cash-paying, HSA-paying, or insured patient more than the posted True Cash Price.
* (b) $0.00 Bill Enforcement and Treble Damages (Month 7 Trigger): Beginning on Day 1 of Month 7 following enactment, any facility or pharmacy that fails to post True Cash Prices under subsection (a) forfeits federal Medicare and Medicaid reimbursement for unposted items. Any bill or charge issued without a posted price—or billed above the posted price—is legally rendered $0.00, null, void, and uncollectible. Reporting a voided bill to a credit bureau or referring it to a third-party debt collector constitutes a per se violation of the Fair Debt Collection Practices Act (15 U.S.C. § 1692 et seq.), entitling the patient to treble damages (three times the billed amount) plus mandatory attorney's fees.
* (c) Group of One Mandate (Month 12 Milestone): Not later than 12 months after enactment, every individual buyer and Form 1099 independent contractor purchasing coverage outside of a traditional multi-employee employer group shall be legally classified as a "Group of One" with full eligibility to purchase certified QHC plans at large-corporate group rates, no higher than baseline rates applied to groups of 50 or more employees.
* (d) Interstate Competition (Month 12 Milestone): Not later than 12 months after enactment, any certified QHC plan approved in one state may be offered, marketed, and sold in all 50 states, fully preempting state benefit mandates and geographic sales restrictions pursuant to Article I, Section 8, Clause 3 of the United States Constitution.
* (e) Telehealth Freedom: Healthcare providers licensed in one state are authorized to treat patients in all 50 states via telehealth without physical brick-and-mortar office requirements or in-state licensing barriers.
* (f) Certificate of Need (CON) Preemption and Medicaid Condition (12 and 18-Month Milestones): Not later than 12 months after enactment, all state CON laws and institutional approval programs are preempted under the Commerce Clause (Article I, Section 8, Clause 3) for any medical facility or provider accepting Medicare, Medicaid, or QHC payments. To enforce compliance within the 18-month implementation window:
* (1) Month 12 Milestone: Federal Medicaid administrative matching funds to any state maintaining active CON laws shall be immediately reduced by 7.5 percent pursuant to Congress's spending power.
* (2) Month 18 Hard-Stop Milestone: If full CON repeal is not certified by 18 months—coinciding with the mandatory Phase 2 ESI conversion and institutional compliance deadline—federal Medicaid administrative matching funds to the non-compliant state shall be reduced by an additional 7.5 percent (totaling a 15 percent reduction), remaining at that level until full repeal is certified.
* (g) Front-Line Provider Empowerment and Chiropractic Parity:
* (1) Nurse Practitioners and Physician Assistants shall exercise full independent prescriptive and clinical practice authority within their certified scope.
* (2) Registered Nurses are authorized to renew non-controlled maintenance medications for up to 180 days for stable patients with a documented history; Licensed Practical Nurses are authorized for 90-day refills if patient vitals are stable.
* (3) Pharmacists are authorized for "Test and Treat" protocols (including Strep, Influenza, and Urinary Tract Infections), clinical dosage adjustments, and walk-in clinical evaluations.
* (4) Chiropractic care is defined as an essential medical service; certified QHC plans are prohibited from requiring a physician referral or imposing visit caps more restrictive than those applied to physical therapy or primary care.
SECTION 4. DISMANTLING VERTICAL INTEGRATION AND PBM REFORM
* (a) Mandatory Structural Separation: No corporate entity or parent company may simultaneously own or control a Health Insurance Carrier, a Pharmacy Benefit Manager (PBM), and a Hospital or Provider Group. Integrated healthcare conglomerates shall complete operational firewalling within 12 months and full legal divestiture into independent companies within 18 months of enactment.
* (b) PBM Accountability: Pharmacy Benefit Managers are prohibited from retaining manufacturer rebates; 100 percent of all rebates shall be applied at the point of sale to reduce the patient's out-of-pocket cost. Spread pricing—charging a health plan more for a prescription drug than the amount paid to the dispensing pharmacy—is strictly prohibited.
SECTION 5. PHASE 2 — MANDATORY ESI CONVERSION, ERISA OVERRIDE, AND HSA ACTIVATION
* (a) Pre-Conversion Notice and HSA Setup (Months 12 to 18): Between Month 12 and Month 18 following enactment, every employer providing ESI shall calculate each worker's total employer-paid ESI allocation and issue written notice of that exact dollar amount. During this period, each worker shall independently establish a personal Health Savings Account (HSA) under 26 U.S.C. § 223 and provide account routing details to the employer to ensure zero coverage gap.
* (b) ERISA Override and Hard-Stop Trigger (Month 19): Notwithstanding the Employee Retirement Income Security Act of 1974 (ERISA, 29 U.S.C. § 1001 et seq.), the Internal Revenue Code (26 U.S.C. § 1 et seq.), or any other federal, state, or collective bargaining provision, Phase 2 conversion shall take automatic, unconditional legal effect nationwide at 12:01 AM on the first day of Month 19 following enactment without administrative delay or waiver.
* (c) ESI Property Definition and Zero Out-of-Pocket Guarantee: Employer ESI is legally defined strictly as the cash amount an employer allocates, budgets, or pays for an employee's health coverage (excluding employee paycheck contributions) and constitutes earned compensation belonging exclusively to the worker. Neither the employer nor the employee shall be assessed any new out-of-pocket payroll tax, and no portion of this conversion shall reduce a worker's base wages, salary, or hourly compensation.
* (d) 15.3 Percent FICA Extraction and Tax-Free Worker Deposit: Prior to HSA disbursement, 15.3 percent of the pure employer-paid ESI transfer shall be deducted pursuant to 26 U.S.C. §§ 3101 and 3111 and remitted to the Treasury for the Part B Premium Elimination Fund established under Section 7. The remaining 84.7 percent of the employer ESI pool, plus 100 percent of any employee payroll health contributions (which remain 100 percent exempt from FICA extraction pursuant to 26 U.S.C. § 3121), shall be deposited directly by the employer into the worker's personal HSA, fully exempt from federal, state, and local income taxation.
* (e) Dual-Use Freedom: Workers may deploy personal HSA funds entirely at their own discretion to purchase a certified QHC plan at Group of One rates established under Section 3(c), or to pay cash directly for medical, surgical, diagnostic, or pharmaceutical care. Unspent HSA balances remain the permanent property of the worker and roll over annually without forfeiture.
SECTION 6. THE 1099 SELF-REIMBURSEMENT MANDATE
* (a) Redirection: Because an independent Form 1099 worker acts as both employer and employee under 26 U.S.C. § 1401 et seq., the 7.65 percent employer-share of self-employment tax paid by the worker shall be redirected from the Treasury directly into the worker's personal HSA (26 U.S.C. § 223) upon filing or quarterly remittance.
* (b) Purpose and Parity: Redirected funds are designated to purchase certified QHC coverage with unlimited lifetime maximums or pay qualified medical and pharmaceutical expenses directly, establishing full healthcare tax parity with corporate W-2 workers under 26 U.S.C. §§ 105 and 106.
SECTION 7. MEDICARE PART B PREMIUM ELIMINATION FUND AND STATE RELIEF
* (a) Elimination of Part B Premiums: Notwithstanding 42 U.S.C. § 1395r, the Secretary of the Treasury shall administer all revenue remitted under Section 5(d) exclusively to eliminate monthly Medicare Part B premiums for all beneficiaries, setting the beneficiary premium rate at $0.00 nationwide.
* (b) Termination of State Buy-In Obligations: Notwithstanding 42 U.S.C. § 1396u-3, all state-level Medicare Part B premium buy-in agreements and mandatory funding obligations are terminated and rendered null and void upon enactment of Phase 2. All savings realized by states through eliminated buy-in obligations and reduced state-share Medicaid costs shall remain strictly within respective state general revenues.
* (c) Surplus Transfer: Any annual surplus remaining in the Fund after eliminating all Part B premiums and covering state buy-in obligations shall be transferred directly to the Social Security OASI Trust Fund.
SECTION 8. SOCIAL SECURITY INTEGRITY AND SOLVENCY
* (a) Mandatory Federal Savings Redirect: An amount equal to 100 percent of certified annual net federal savings resulting from Phase 1 and Phase 2 reforms—including eliminated Medicare Part B General Revenue expenditures (42 U.S.C. § 1395r), eliminated federal Medicaid buy-in matching outlays, reduced Federal Employee Health Benefits (FEHB) costs, eliminated Medicare Advantage and Part D overpayments, and lowered federal agency healthcare procurement costs ($40 billion to $58 billion annually)—shall be calculated annually by the Secretary of the Treasury and transferred directly into the Social Security OASI Trust Fund.
SECTION 9. INSTITUTIONAL COMPLIANCE AND ENFORCEMENT
* (a) Statutory Authority: Under the Taxing and Commerce Powers of the United States Constitution (Article I, Section 8), any healthcare institution, hospital network, health system, retail pharmacy, PBM, or corporate medical entity that fails to comply with the structural, transparency, or market liberation mandates of this Act shall incur the following escalating monthly non-deductible excise taxes on total gross corporate revenues and commercial disqualifications:
* (1) Tier 1 (30 Days Non-Compliance): Immediate 10 percent monthly excise tax on total gross corporate revenues and forfeiture of federal tax-exempt status under 26 U.S.C. § 501(c)(3) for the duration of non-compliance.
* (2) Tier 2 (90 Days Non-Compliance): 25 percent monthly excise tax on total gross corporate revenues and legal disqualification from processing payments or claims from any certified QHC plan or participating in interstate healthcare commerce networks.
* (3) Tier 3 (180 Days Non-Compliance): 50 percent monthly excise tax on total gross corporate revenues until full structural and pricing compliance is certified.
* (b) Immediate Cessation: All excise taxes and commercial bans shall cease immediately upon formal federal certification of full compliance.
SECTION 10. SEVERABILITY
If any provision of this Act, or the application thereof to any person or circumstance, is held invalid or unconstitutional, the remainder of this Act and the application of such provision to other persons or circumstances shall not be affected thereby and shall remain in full force and effect.
CONCLUSION: FISCAL AND ECONOMIC IMPACT SUMMARY
This Act proves that America does not have a healthcare funding shortage—it has a structural monopoly and tax-code distortion problem. By closing the 1954 FICA loophole on the pure employer-paid portion of Employer-Sponsored Insurance without adding a single dime in new out-of-pocket payroll taxes on workers or employers, this Act delivers an immediate, permanent economic dividend across the entire nation:
* Direct Relief for 65 Million Seniors: Eliminating the $202.90 monthly Medicare Part B deduction restores $2,434.80 per year directly into the Social Security checks of individual seniors—and nearly $4,870 per year for married senior couples—generating immediate local Main Street consumer spending without new federal outlays.
* $25 Billion to $30 Billion Annual State Windfall: Terminating mandatory state Medicare Part B buy-in payments frees $25 billion to $30 billion every year across state budgets for infrastructure, tax relief, or local priorities.
* Social Security Solvency Reinforcement: Dedicating $40 billion to $58 billion annually in realized federal healthcare savings—plus annual Part B Fund surpluses—fortifies the Social Security OASI Trust Fund without raising payroll tax rates or cutting retirement benefits.
Authored by: John Dady
Email: jbd10611@yahoo.com
Websites: iwriteyoushare.com | citizensagainsttyranny.net